1-7 of 7
Fiamma Buttitta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effective Assessment of egfr Mutation Status in Bronchoalveolar Lavage and Pleural Fluids by Next-Generation Sequencing

Fiamma Buttitta, Lara Felicioni, Maela Del Grammastro, Giampaolo Filice, Alessia Di Lorito, Sara Malatesta, Patrizia Viola, Irene Centi, Tommaso D'Antuono, Roberta Zappacosta, Sandra Rosini, Franco Cuccurullo, Antonio Marchetti
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (3): 691–698.
https://doi.org/10.1158/1078-0432.CCR-12-1958
Published: 31 January 2013
View article titled, Effective Assessment of <em>egfr</em> Mutation Status in Bronchoalveolar Lavage and Pleural Fluids by Next-Generation Sequencing
Open the PDF for Effective Assessment of <em>egfr</em> Mutation Status in Bronchoalveolar Lavage and Pleural Fluids by Next-Generation Sequencing in another window
Includes: Supplementary data
Journal Articles

Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer

Francesca Molinari, Lara Felicioni, Michela Buscarino, Sara De Dosso, Fiamma Buttitta, Sara Malatesta, Alessandra Movilia, Marco Luoni, Renzo Boldorini, Oscar Alabiso, Salvatore Girlando, Barbara Soini, Alessandra Spitale, Federica Di Nicolantonio, Piercarlo Saletti, Stefano Crippa, Luca Mazzucchelli, Antonio Marchetti, Alberto Bardelli, Milo Frattini
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (14): 4901–4914.
https://doi.org/10.1158/1078-0432.CCR-10-3137
Published: 17 July 2011
View article titled, Increased Detection Sensitivity for <em>KRAS</em> Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
Open the PDF for Increased Detection Sensitivity for <em>KRAS</em> Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer in another window
Journal Articles

Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the PIK3CA Gene in Breast Carcinomas

Mattia Barbareschi, Fiamma Buttitta, Lara Felicioni, Sabrina Cotrupi, Fabio Barassi, Maela Del Grammastro, Antonella Ferro, Paolo Dalla Palma, Enzo Galligioni, Antonio Marchetti
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (20): 6064–6069.
https://doi.org/10.1158/1078-0432.CCR-07-0266
Published: 18 October 2007
View article titled, Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the <em>PIK3CA</em> Gene in Breast Carcinomas
Open the PDF for Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the <em>PIK3CA</em> Gene in Breast Carcinomas in another window
Journal Articles

Int6 Expression Can Predict Survival in Early-Stage Non–Small Cell Lung Cancer Patients

Fiamma Buttitta, Carla Martella, Fabio Barassi, Lara Felicioni, Simona Salvatore, Sandra Rosini, Tommaso D'Antuono, Antonio Chella, Felice Mucilli, Rocco Sacco, Andrea Mezzetti, Franco Cuccurullo, Robert Callahan, Antonio Marchetti
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3198–3204.
https://doi.org/10.1158/1078-0432.CCR-04-2308
Published: 02 May 2005
View article titled, Int6 Expression Can Predict Survival in Early-Stage Non–Small Cell Lung Cancer Patients
Open the PDF for Int6 Expression Can Predict Survival in Early-Stage Non–Small Cell Lung Cancer Patients in another window
Journal Articles

Down Regulation of High in Normal-1 ( HIN-1 ) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome

Antonio Marchetti, Fabio Barassi, Carla Martella, Antonio Chella, Simona Salvatore, Antonio Castrataro, Felice Mucilli, Rocco Sacco, Fiamma Buttitta
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1338–1343.
https://doi.org/10.1158/1078-0432.CCR-1174-03
Published: 20 February 2004
View article titled, Down Regulation of High in Normal-1 ( <em>HIN-1</em> ) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome
Open the PDF for Down Regulation of High in Normal-1 ( <em>HIN-1</em> ) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome in another window
Journal Articles

HER-2/Neu Alterations in Non-Small Cell Lung Cancer: A Comprehensive Evaluation by Real Time Reverse Transcription-PCR, Fluorescence in Situ Hybridization, and Immunohistochemistry

Caterina Pellegrini, Monica Falleni, Antonio Marchetti, Barbara Cassani, Monica Miozzo, Fiamma Buttitta, Massimo Roncalli, Guido Coggi, Silvano Bosari
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3645–3652.
Published: 23 September 2003
View article titled, HER-2/Neu Alterations in Non-Small Cell Lung Cancer: <subtitle>A Comprehensive Evaluation by Real Time Reverse Transcription-PCR, Fluorescence <em>in Situ</em> Hybridization, and Immunohistochemistry</subtitle>
Open the PDF for HER-2/Neu Alterations in Non-Small Cell Lung Cancer: <subtitle>A Comprehensive Evaluation by Real Time Reverse Transcription-PCR, Fluorescence <em>in Situ</em> Hybridization, and Immunohistochemistry</subtitle> in another window
Journal Articles

Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer

Antonio Marchetti, Gloria Bertacca, Fiamma Buttitta, Antonio Chella, Gianluca Quattrocolo, Carlo Alberto Angeletti, Generoso Bevilacqua
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 2077–2081.
Published: 01 August 1999
View article titled, Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer
Open the PDF for Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer in another window